Reproductive Health and HIV Research Unit *
*
* *
> search site
> site map
> contact us
> link to us
RHRU is a WHO collaborating centre

HPV Vaccine Study

Project Focus
HPV infection

Project Location
Durban KwaZulu-Natal, South Africa

Duration of Project
2005 - 36 months

Project Partners
Cinicians and community members

Project Donors
MSD

Contact Details
Dr Arthi Ramkissoon

Project Aim/ Objectives
Aim
To evaluate the efficacy of quadrivalent HPV (Types 6, 11, 16, and 18) vaccine in reducing the incidence of  HPV 6-, 11-, 16-, and 18-related anogenital warts, and the incidence of HPV 6-, 11-, 16-, and 18-related genital infection in young men. 

Project Activities 

  • Recruitment, screening & enrolment of 24 participants.
  • Vaccination and post-vaccination follow-up for safety and efficacy for three years.
  • Regular ongoing HIV testing of participants

 

Anticipated/Actual Results
  • Vaccine - induced serum antibody responses to HPV 6, 11, 16, 18
  • Safety of dose regimen of quadrivalent HPV vaccine
  • Incidence of HPV related anogenital warts
  • Incidence of HPV 6, 11, 16, 18 detection/infection


Additional Outputs

  • Condom use and sexual risk behaviour in young men


Future Plans

  • none

 


 


Projects in the STI's & HIV Research Cluster:



Comment On Page | Tell A Friend | Bookmark | Print Page
 
 


designed by litmus digital